百日咳博德特氏菌降解菌株的抗生素耐药性。
Antibiotic resistance of degraded strains of Bordetella pertussis.
作者信息
Bannatyne R M, Cheung R
出版信息
Antimicrob Agents Chemother. 1984 Apr;25(4):537-8. doi: 10.1128/AAC.25.4.537.
Abstract
The susceptibilities to erythromycin, rifampin, polymyxin B, ampicillin, tetracycline, gentamicin, fusidic acid, trimethoprim, and spectinomycin of five virulent phase I strains of Bordetella pertussis and their degraded phase IV descendants were compared. Increases in MICs of 2- to 16-fold were observed for erythromycin, rifampin, tetracycline, fusidic acid, trimethoprim, and spectinomycin for four of the five degraded strains.
摘要
比较了五株I相强毒株百日咳博德特氏菌及其IV相退化后代对红霉素、利福平、多粘菌素B、氨苄西林、四环素、庆大霉素、夫西地酸、甲氧苄啶和壮观霉素的敏感性。在五株退化菌株中的四株中，观察到红霉素、利福平、四环素、夫西地酸、甲氧苄啶和壮观霉素的最低抑菌浓度（MIC）增加了2至16倍。
相似文献
1
Antibiotic resistance of degraded strains of Bordetella pertussis.
Antimicrob Agents Chemother. 1984 Apr;25(4):537-8. doi: 10.1128/AAC.25.4.537.
2
Antimicrobial susceptibility of Bordetella pertussis strains isolated from 1960 to 1981.
Antimicrob Agents Chemother. 1982 Apr;21(4):666-7. doi: 10.1128/AAC.21.4.666.
3
Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.
Antimicrob Agents Chemother. 1988 Jan;32(1):137-40. doi: 10.1128/AAC.32.1.137.
4
[Susceptibility testing and molecular epidemiology of clinical strains of Bordetella pertussis isolated in Japan from 2001 to 2002].
Kansenshogaku Zasshi. 2004 May;78(5):420-7. doi: 10.11150/kansenshogakuzasshi1970.78.420.
5
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Cent Eur J Public Health. 2017 Dec;25(4):282-286. doi: 10.21101/cejph.a4948.
6
Antibiotic susceptibility testing of Bordetella pertussis.
Am J Clin Pathol. 1980 Sep;74(3):312-6. doi: 10.1093/ajcp/74.3.312.
7
A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
J Clin Microbiol. 2000 Mar;38(3):1151-5. doi: 10.1128/JCM.38.3.1151-1155.2000.
8
In-vitro sensitivity of Bordetella pertussis.
J Antimicrob Chemother. 1983 May;11(5):407-11. doi: 10.1093/jac/11.5.407.
9
Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
Medicine (Baltimore). 2021 Jan 15;100(2):e24090. doi: 10.1097/MD.0000000000024090.
10
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Antimicrob Agents Chemother. 1998 Apr;42(4):965-6. doi: 10.1128/AAC.42.4.965.
引用本文的文献
1
A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
J Clin Microbiol. 2000 Mar;38(3):1151-5. doi: 10.1128/JCM.38.3.1151-1155.2000.
2
Decrease in antimicrobial susceptibility of Bordetella bronchiseptica caused by antigenic modulation and phase variation.
Antimicrob Agents Chemother. 1988 Dec;32(12):1891-2. doi: 10.1128/AAC.32.12.1891.
3
Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.
Antimicrob Agents Chemother. 1988 Jan;32(1):137-40. doi: 10.1128/AAC.32.1.137.
本文引用的文献
1
Antimicrobial susceptibility of Bordetella pertussis strains isolated from 1960 to 1981.
Antimicrob Agents Chemother. 1982 Apr;21(4):666-7. doi: 10.1128/AAC.21.4.666.
2
Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis.
Infect Immun. 1982 Mar;35(3):840-51. doi: 10.1128/iai.35.3.840-851.1982.
3
Phase-shift markers in Bordetella: alterations in envelope proteins.
J Infect Dis. 1981 Apr;143(4):562-9. doi: 10.1093/infdis/143.4.562.
4
A simple chemically defined medium for the production of phase I Bordetella pertussis.
J Gen Microbiol. 1970 Oct;63(2):211-20. doi: 10.1099/00221287-63-2-211.
Zotero 插件